Background and aim: Takotsubo cardiomyopathy (TC) is an important differential diagnosis of coronary artery disease (CAD), mimicking acute coronary syndrome in clinical symptoms, biomarker profiles and ST-elevation in ECG. Absence of occlusive coronary disease is an essential criterion distinguishing both diseases. The aim of the study was to explore the influence of co-existing incidental CAD on poorer clinical outcomes and all-cause mortality in TC. Design, methods and results: Our mono-centric study cohort constituted 114 consecutive patients diagnosed with TC between 2003 and 2015. The primary endpoint was the all-cause mortality. Additionally, we compared the incidence of thromboembolic events, life-threatening arrhythmias, cardiogenic shock and in-hospital death. There was no significant difference in gender distribution or mean age in both groups. Patients diagnosed with a co-existing CAD (n ¼ 22), had a more pronounced cardiovascular risk profile. The all-cause mortality among patients with co-existing CAD after a 2-year follow-up was higher than those diagnosed with lone TC (22.7 vs. 5.4 %, P ¼ 0.07). In a multivariate cox regression analysis CAD (HR 3.5,; P ¼ 0.04), LVEF 35% (HR 3.8, 95% CI 0.0-0.6, P ¼ 0.01) and cardiogenic shock (HR 3.8, 95% CI 1.2-11.3; P ¼ 0.01) were independent predictors of the primary endpoint. Conclusion: Our study reveals that co-existing CAD impairs the outcome in patients with TC. The diagnostic work-up for TC should therefore not necessarily hinge on ruling out CAD.
Introduction
Takotsubo cardiomyopathy (TC) is an acute reversible cardiomyopathy characterized by transient left ventricular (LV) apical ballooning. 1 Although involvement of the apical part of the left ventricle is a definitive distinguishing feature, mid-ventricular, 2 basal or isolated parts can also be affected. 3 In majority of the patients diagnosed with TC, triggering factors have been attributed to some form of acute mental, emotional or physical stress and the clinical symptoms, biomarker profiles and STelevation in ECG usually mimic an acute coronary syndrome (ACS). 4 Interestingly, postmenopausal women have been predominantly found to be affected by TC. 5 Although the diagnostic criteria for TC stipulates the absence of significant coronary artery disease (CAD), its trigger factors, like emotional and physical stress have been well-documented as risk factors for development of CAD. This study attempts to explore the potential relationship of CAD presenting in patients with angina-like symptoms, where fear of a chronic disease and impending doom could prove a trigger for an acute episode of TC.
Methods
We retrospectively studied a collective of 114 consecutive patients diagnosed with TTC at our institution between January 2003 and September 2015. Patients were diagnosed according to the Mayo Clinic Criteria, 6 which outlines the clinical features associated with TC. The first criterion describes the transient wall motion abnormality in the LV mid segments with or without apical involvement; regional wall motion abnormalities that extend beyond a single epicardial vascular distribution and frequently, but not always in the event of a stressful trigger. The second criterion stipulates the absence of obstructive coronary disease. The third criterion outlines the appearance of new ECG pathologies, which mimic ACS or modest elevations in cardiac troponin levels. The final criterion is the absence of pheochromocytoma and myocarditis in the patient. The patients were divided into two groups based on the presence or absence of CAD at admission. A diagnosis of CAD was only established after the conduct of a coronary angiography. 7 The angiograms, echocardiograms and ECG were reviewed by two experienced cardiologists, who independently evaluated the diagnosis of TTC. Patients were excluded from our analysis when the opinion of these reviewers differed. 18 patients with uncertain TC, either due to absence of a coronary angiogram and/or follow-up echocardiogram were excluded from this study. In-hospital events, arrhythmias, cardiac rupture, thromboembolic events, pulmonary congestion with use of non-invasive positive-pressure ventilation, intubation, use of a temporary pacemaker, use of inotropic agents and in-hospital death were assessed retrospectively at index event of TC and during followup of 563 6 276 days based on chart review. The maximum follow-up was 733 days and the minimum follow-up was 0 days. The primary end point of our study was the all-cause mortality as assessed by chart review and/or telephone review. If medical records, treating physicians or relatives were unable to provide further information concerning the circumstances of death, it was defined as death due to unknown cause.
This study was conducted in compliance with the Declaration of Helsinki concerning investigations in human subjects and the study protocol was approved by the Ethics Committee of University Medical Centre Mannheim.
Statistics
Continuous variables with normal distribution are shown as mean 6 SD, those who had a non-normal distribution as median (interquartile range). The student's t-test was used to determine statistically significant differences in variables with normal and non-normal distributions. Qualitative variables were analysed by the chi-square test or Fisher's exact test. To compare survival curves between CAD and non-CAD group, the log-rank test was used. All statistical calculations were performed using SPSS. A P values 0.05 was considered significant.
Results
We analysed the influence of coexisting CAD among the 114 patients diagnosed with TC between January 2003 to September 2015, by drawing a parable to their clinical and echocardiographic data. 
Baseline demographics
There was no significant difference in gender distribution or mean age between patients constituting the two groups. Patients concomitantly diagnosed with CAD (19.2%) had a higher comorbidity index with a greater incidence of diabetes mellitus (19.6 vs. 36.3%, P ¼ 0.09) and arterial hypertension (54.3 vs. 72.3%, P ¼ 0.03) as compared to the lone TC patient group (80.8%), TC without coexisting CAD).
Physical stress, in comparison to emotional factors, was often the trigger for the acute phase of TC (56.5% in Non-CAD group and 54.5% in CAD group). The impact of the emotional triggers was more pronounced in the CAD group (45.5 vs. 21.7%, s. Table 1 ). Baseline clinical, electrocardiographic and echocardiographic characteristics of patients diagnosed with TC, with and without relevant CAD are shown in Table 1 .
Clinical presentation
Patients with concomitant TC and CAD presented more often with chest pain than patients with lone TC (44.6 vs. 77.3%, P < 0.01). Despite lack of significant difference in heart rate and Results derived from the coronary angiography indicated that a significant group of patients suffered from a single-vessel CAD (45.45%). The incidence of a triple-vessel CAD (31.8%) was slightly greater than double-vessel CAD (22.7%). It is pertinent to note symptoms mimicking ACS in all patients were never triggered by the critical narrowing of a coronary vessel. Additionally, none of the patients included in this study needed coronary revascularization at index presentation (percutaneous or surgical).
In-hospital events and treatment strategy As highlighted in Table 2 , there was no difference in critical events like life-threatening arrhythmia, need for endotracheal intubation, use of inotropic agents, cardio-pulmonary resuscitation, defibrillator implantation, In-hospital death, thromboembolic events or cardiogenic shock. However, a significant difference in the ejection fraction and the frequency of cardiogenic shock at index event could be demonstrated (HR 7.16, 95% CI 2.4-21.2, HR 5.74, 95% CI 2.3-14.1 P < 0.01). Figure 1 shows the Kaplan-Meier curve for overall survival of patients suffering from TC and CAD and patients with TC without CAD (lone TC). A follow-up after two years revealed that the survival of patients with TC and concomitant CAD was numerically lower as compared to patients with lone TC (77.3 vs. 94.6%, P ¼ 0.07). Results of the Cox univariate analysis suggested that male gender (HR 2.2, 95% CI: 0.8-5.7; P ¼ 0.09), ejection fraction 35 (HR 7.1, 95% CI: 2.4-21.1; P < 0.01), CAD (HR 2.2, 95% CI 0.9-5.5; P ¼ 0.08), cardiogenic shock (HR 5.74, 95% CI 2.3-14.1; P < 0.01), history of cancer (HR 2.7, 95% CI 1.0-7.0; P ¼ 0.04) and C-reactive protein values (HR 1.0; 95% CI 1.0-1.0; P < 0.01) were associated with the primary end-point. The multivariate cox regression analysis further suggested that CAD (HR 3.5, 95% CI 1.0-11.6; P ¼ 0.04), ejection fraction 35% (HR 3.8, 95% CI 0.0-0.6, P ¼ 0.01) and cardiogenic shock (HR 3.8, 95% CI 1.2-11.3; P ¼ 0.01) were the only independent predictors of the primary end point ( Table 3) .
Long-term outcome
The causes of death in patients with concomitant TC and CAD were either cardiogenic shock (42.9%), cardiac arrest (14.3%), pulseless electrical activity (PEA, 14.3%), renal failure (14.3%) or multi-organ failure (14.3%).
In patient suffering from lone TC, the most common identifiable cause of death was either cancer (26.7%) or due to an unknown cause (33.3%). The death of three (20%) patients was attributed to heart failure, while 13.3% of the patients died due to a cerebral insult. 6.7% of the patients died due to respiratory failure.
Recurrent cases of TC were documented on incidental follow-up (CAD group 1 case versus 4 cases of non-CAD group), however no cases of myocardial infarction were observed in any of the patient groups.
Discussion
In this retrospective study of TC patients, the prevalence of coexisting CAD was around 19%. The Mayo Clinic Criteria has deemed the absence of significant CAD as essential to the diagnosis of TC. 6 However, this criterion can be called into question in the setting of a diagnosed TC patient with co-existing CAD. It is therefore pertinent to conclusively differentiate significant coronary stenosis with corresponding ischemic regional wall motion abnormalities from an incidental concomitant non- relevant CAD. Previous studies have reported the existence of CAD among TC patients, 8 with minimally higher rates of prevalence as compared to our study. [9] [10] [11] As suspected, the cardiovascular risk factor profile as well as the observed blood pressure was higher in the CAD group. This knowledge may help stratify the probability of co-existing CAD. We also found that emotional stress had a more pronounced effect as trigger contributing to the development of TC in patients with concomitant CAD.
It has already been demonstrated by Low et al., that progression in CAD, especially in postmenopausal woman may be accelerated by psychosocial risk factors. 12 One could then hypothesize that patients suffering from TC and CAD seem to be predisposed to the effects of emotional stresses. Additionally, we found a relatively greater incidence of thromboembolic events that did not differ in both groups (13% in Non-CAD-group, 9% in CAD group). A satisfying explanation to the underlying pathogenesis and higher rate of thromboembolic events in TC remains unresolved. In TC, the development of an acute ventricular thrombus 13 is presumably explained by the triad of Virchow, with the low blood flow in the ventricle, singled out as cause in this scenario. The improvement of wall motion abnormality in TC might promote discharge of this intraventricular thrombus into the peripheral bloodstream, thus initiating an embolic event. Another hypothesis involving the coagulation cascade has also been recently proposed as the underlying mechanism contributing to the development of thromboemboli in TC patients. 14 Recent studies have underlined the role of endothelial dysfunction and similar pathologies contributing to the hyper-viscosity of blood flow in TC. 15 Inflammation might play an important role in the development of thromboembolic events, as already discussed in another research paper published in this series. 16 However, the lack of more data relegates us to case reports documenting the prevalence of thromboembolic events in TC. [17] [18] [19] [20] Our study suggested a numerically lower overall survival rate for patients suffering from TC and concomitant CAD. Mortality due to any cause, accounted for during hospitalization and follow-up, revealed death at index TC event of three patients with concomitant CAD versus six patients without CAD; after 1 year, of five patients with CAD versus nine patients without CAD; and after 2 years, of seven patients with CAD versus 14 patients without CAD. Current data suggests the all-cause-mortality in patients with CAD at 5-8% per year, depending essentially on the severity of involved coronary arteries, the age of the patients and applied therapeutic management strategies. 21, 22 As the follow-up in our study was restricted to 2 years, an exact parable cannot be drawn with current data, however, it does give the general impression that the overall-mortality of patients suffering from TC and CAD is higher than patients with lone CAD.
To the best of our knowledge, there is no data available suggesting the long-term influence of coexisting CAD on the mortality rate in patients diagnosed with TC. It is well known that all kinds of acute mental, emotional or physical stress can trigger an acute episode of TC. 4 There also exist case reports that suggest ACS could be one such trigger. [23] [24] [25] [26] In contrast to our findings, Najib et al. 27 saw no significant difference in in-hospital mortality between TC patients without CAD and TC patients with CAD. However, in his study, the non-CAD group included a cohort of different diseases like peri-myocarditis, coronary artery vasospasm, spontaneous coronary artery dissection or valvular pathologies. Another previous study demonstrated that the midterm outcome of patients with TC (6 month follow-up) was not significantly influenced by the presence of relevant coronary artery stenosis. 11 Our study, however, demonstrated that mortality rates differed after a period of 2 years.
To exclude the influence of other comorbidities that could define a worse outcome we performed a univariate and multivariate analysis of our data. A limitation inherent to this retrospective analysis was the use of eyeball estimation to decide if a coronary stenosis was significant. This subjective criteria has been offset by modern techniques like measurement of fractional flow reserve (FFR), optical coherence tomography (OCT) and intravascular ultrasound (IVUS) which serve as the gold standard to assess the significance of coronary artery stenosis. [28] [29] [30] [31] Therefore, critical coronary artery stenosis could have been underestimated and consequently be a reason for a worse outcome in patients with CAD. Another explanation for a lower overall survival in the CAD patient group, is attributed to the chronic progressive nature of CAD. It could naturally be assumed that the chronic progress in CAD leads to an ischemic cardiomyopathy which contributes to a higher all-cause mortality for patients with TC and concomitant CAD. Due to the observation that mortality rate does not increase immediately but after two years, ACS could be a trigger for TC, but this is not the definitive reason contributing to an increase in the mortality rate. Most patients in our CAD cohort died due to a cardiac cause (cardiogenic shock and cardiac arrest). This underlines the thesis that chronic progress of CAD or acute rupture of a plaque of an intermediate coronary lesion could lead to heart failure leading to a poorer clinical outcome. Unfortunately, we have no echocardiographic data documenting the ejection fraction in patients after 2 years, particularly of those patients who died. Further investigations are essential to clarify the longterm influence of heart failure and thereby the context and reason for worse outcome.
Study limitations
Our study had some limitations; first, this was a single-center retrospective observational study including patients admitted over the period of 13 years. Additionally, the degree of coronary artery stenosis was not assessed by FFR and no other ischemia tests like IVUS or OCT for plaque characterization were performed. Furthermore, we have little information concerning the progress of CAD and the evolution of the cardiovascular risk factor profile after the period of follow-up. A second-look Coronary angiography would be helpful in this regard. Thus, we cannot conclusively rule out the rapid progress of CAD in patients with a more significant cardiovascular risk profile.
Conclusion
The coexistence of CAD seems to impair the outcome of patients with TC. Therefore, it is essential to keep in mind that a diagnosis of TC does not fully eliminate the possibility of ACS. Additionally, there is a strict need to treat the cardiovascular comorbidities in patients with TC and concomitant CAD.
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